Skip to main content
. 1999 Nov;73(11):9404–9412. doi: 10.1128/jvi.73.11.9404-9412.1999

TABLE 3.

Genetic distances to MRCAsa

Patient Method MRCA-to-base plasma virus distance ± SE (%) No. of clones analyzed MRCA-to-year 2 viral isolate ± SE (%) No. of clones analyzed Wilcoxon rank sum (P) Difference mean branch lengths to MRCA
A BL 4.194 ± 0.287 9 4.062 ± 0.273 10 0.667 −0.132
DD 3.892 ± 0.226 4.210 ± 0.238 0.44 0.318
B BL 0.233 ± 0.043 10 0.022 ± 0.037 13 0.0023 −0.21
DD 0.232 ± 0.043 0.022 ± 0.037 0.0023 −0.21
C BL 3.345 ± 0.427 9 5.491 ± 0.427 10 0.001 2.146
DD 2.696 ± 0.164 2.731 ± 0.164 0.507 0.035
K BL 1.67 ± 0.089 7 1.924 ± 0.074 10 0.0208 0.254
DD 1.677 ± 0.092 1.912 ± 0.077 0.07 0.235
L BL 2.16 ± 0.142 10 0.114 ± 0.135 10 0.0002 −2.046
DD 1.67 ± 0.141 1.276 ± 0.134 0.112 −0.39
M BL 2.72 ± 0.166 10 6.56 ± 0.198 7 0.0006 3.84
DD 2.584 ± 0.272 5.251 ± 0.326 0.0006 2.67
a

Genetic distances to MRCA from plasma-derived sequences and year 2 viral isolates by summation of branch lengths (BL) generated with fastDNAML (7, 30) or direct calculation from sequences (DD) generated with DNAML (PHYLIP 3.6) (7, 8). (The results shown are from analyses based on selection of an MRCA for all plasma and viral isolate sequences.) The standard error (SE) was computed with a pooled estimate of error variance. Wilcoxon rank sums compare values to MRCA from plasma virus with those from year two viral isolates. The difference of mean branch lengths to MRCA were computed by subtracting the mean plasma virus-to-MRCA branch lengths from the mean year 2 viral isolate-to-MRCA branch lengths.